• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高密度脂蛋白与饮食和非诺贝特治疗期间循环总脂联素和高分子量脂联素的变化呈正相关。

High density lipoprotein is positively correlated with the changes in circulating total adiponectin and high molecular weight adiponectin during dietary and fenofibrate treatment.

机构信息

Laboratory of Physiology, Medical School, University of Ioannina, Ioannina, Greece.

出版信息

Hormones (Athens). 2012 Apr-Jun;11(2):178-88. doi: 10.14310/horm.2002.1345.

DOI:10.14310/horm.2002.1345
PMID:22801564
Abstract

OBJECTIVE

The investigation of the relationship between high density lipoprotein (HDL) and adiponectin.

DESIGN

Thirty-seven obese or overweight [body mass index ≥27 Kg/m(2)], hypertriglyceridemic patients underwent one of the following interventions for 3 months: 1) Low-calorie diet (n=19), 2) Low-calorie diet plus fenofibrate (n=18).

RESULTS

Circulating total adiponectin did not change significantly in the low-calorie diet group. However, in the subgroup of patients whose high density lipoprotein cholesterol (HDL-C) decreased over the first month of diet, a statistically significant reduction of the circulating total adiponectin was observed (p=0.010), while in the subgroup of patients whose HDL-C increased over the latter 2 months of the diet, an increase in circulating total adiponectin over the 2 months was found (p=0.043). The percentage change of HDL-C over the first month of diet was positively correlated with the percentage change of circulating total adiponectin (r=0.579, p=0.019). The percentage change of HDL-C over the 3 months of diet was positively correlated with the percentage changes of circulating total adiponectin (r=0.527, p=0.030) and high molecular weight (HMW) adiponectin (r=0.524, p=0.031). The change in circulating total adiponectin over the first month of diet was positively correlated with the HDL-C at 1 month (r=0.606, p=0.013). The change in HMW adiponectin over the 3 months of diet was positively correlated with the HDL-C at 3 months (r=0.602, p=0.011). The percentage change of circulating HMW adiponectin over the first month of fenofibrate treatment was positively correlated with the percentage change of HDL-C (r=0.594, p=0.012).

CONCLUSIONS

HDL is positively correlated with the changes in circulating adiponectin during dietary and fenofibrate treatment.

摘要

目的

研究高密度脂蛋白(HDL)与脂联素之间的关系。

设计

37 名肥胖或超重[体重指数(BMI)≥27kg/m2]、高三酰甘油血症患者接受以下干预措施之一,持续 3 个月:1)低热量饮食(n=19),2)低热量饮食加非诺贝特(n=18)。

结果

低热量饮食组循环总脂联素无明显变化。然而,在第一个月饮食过程中高密度脂蛋白胆固醇(HDL-C)降低的亚组患者中,观察到循环总脂联素的统计学显著降低(p=0.010),而在 HDL-C 在后 2 个月增加的亚组患者中,发现循环总脂联素在这 2 个月中增加(p=0.043)。第一个月饮食期间 HDL-C 的百分比变化与循环总脂联素的百分比变化呈正相关(r=0.579,p=0.019)。3 个月饮食期间 HDL-C 的百分比变化与循环总脂联素(r=0.527,p=0.030)和高分子量(HMW)脂联素(r=0.524,p=0.031)的百分比变化呈正相关。第一个月饮食期间循环总脂联素的变化与第一个月的 HDL-C 呈正相关(r=0.606,p=0.013)。3 个月饮食期间 HMW 脂联素的变化与第三个月的 HDL-C 呈正相关(r=0.602,p=0.011)。非诺贝特治疗第一个月循环 HMW 脂联素的百分比变化与 HDL-C 的百分比变化呈正相关(r=0.594,p=0.012)。

结论

HDL 与饮食和非诺贝特治疗期间循环脂联素的变化呈正相关。

相似文献

1
High density lipoprotein is positively correlated with the changes in circulating total adiponectin and high molecular weight adiponectin during dietary and fenofibrate treatment.高密度脂蛋白与饮食和非诺贝特治疗期间循环总脂联素和高分子量脂联素的变化呈正相关。
Hormones (Athens). 2012 Apr-Jun;11(2):178-88. doi: 10.14310/horm.2002.1345.
2
Fenofibrate increases high molecular weight adiponectin in subjects with hypertriglyceridemia.非诺贝特可增加高甘油三酯血症患者的高分子量脂联素水平。
Endocr J. 2007 Jun;54(3):431-5. doi: 10.1507/endocrj.k06-172. Epub 2007 Apr 25.
3
Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of "heart positive," a randomized, controlled trial.烟酸和非诺贝特联合生活方式改变可改善接受抗逆转录病毒治疗的 HIV 患者的血脂异常和脂联素减少:“心脏阳性”随机对照试验的结果。
J Clin Endocrinol Metab. 2011 Jul;96(7):2236-47. doi: 10.1210/jc.2010-3067. Epub 2011 May 11.
4
Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia.非诺贝特对改善原发性高甘油三酯血症患者内皮功能障碍及提高脂联素水平的有益作用。
Diabetes Care. 2005 Jun;28(6):1419-24. doi: 10.2337/diacare.28.6.1419.
5
Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients.贝特类药物和烟酸缓释剂对血脂异常患者高密度脂蛋白颗粒大小分布和胆固醇流出能力的影响差异。
J Clin Lipidol. 2013 Sep-Oct;7(5):414-22. doi: 10.1016/j.jacl.2013.06.007. Epub 2013 Jun 27.
6
Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot study.利莫那班、微粉化非诺贝特及其联合用药对超重/肥胖患者心血管代谢危险因素的影响:一项初步研究。
Expert Opin Pharmacother. 2008 Nov;9(16):2741-50. doi: 10.1517/14656566.9.16.2741.
7
Preliminary evidence of genetic determinants of adiponectin response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network.降脂药物和饮食网络遗传学中初步证据表明,脂联素对非诺贝特反应的遗传决定因素。
Nutr Metab Cardiovasc Dis. 2013 Oct;23(10):987-94. doi: 10.1016/j.numecd.2012.07.010. Epub 2012 Nov 11.
8
The changes in plasma retinol-binding protein 4 levels are associated with those of the apolipoprotein B-containing lipoproteins during dietary and drug treatment.血浆视黄醇结合蛋白 4 水平的变化与饮食和药物治疗期间载脂蛋白 B 脂蛋白的变化相关。
Angiology. 2012 Jan;63(1):67-75. doi: 10.1177/0003319711407628. Epub 2011 May 20.
9
Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: results from a crossover study.比较贝特类药物和非诺贝特对伴有糖耐量受损或 2 型糖尿病的血脂异常患者循环蛋白转化酶枯草溶菌素/前胰蛋白酶 9 和脂肪细胞因子水平的影响:一项交叉研究的结果。
Atherosclerosis. 2011 Jul;217(1):165-70. doi: 10.1016/j.atherosclerosis.2011.02.012. Epub 2011 Feb 22.
10
Genetic and environmental determinants of total and high-molecular weight adiponectin in families with low HDL-cholesterol and early onset coronary heart disease.家族性低高密度脂蛋白胆固醇血症和早发冠心病患者中总及高分子量脂联素的遗传和环境决定因素。
Atherosclerosis. 2010 Jun;210(2):479-85. doi: 10.1016/j.atherosclerosis.2009.12.022. Epub 2009 Dec 21.

引用本文的文献

1
Impact of HCV elimination on metabolism markers in people living with HIV.丙型肝炎病毒消除对HIV感染者代谢标志物的影响。
Sci Rep. 2025 May 29;15(1):18937. doi: 10.1038/s41598-025-99107-4.
2
Predictive biomarkers for cardiometabolic risk in postmenopausal women: insights into visfatin, adropin, and adiponectin.绝经后女性心脏代谢风险的预测生物标志物:对内脂素、内泌素和脂联素的见解
Front Endocrinol (Lausanne). 2025 Feb 7;16:1527567. doi: 10.3389/fendo.2025.1527567. eCollection 2025.
3
Sex-Related Differences in the Associations between Adiponectin and Serum Lipoproteins in Healthy Subjects and Patients with Metabolic Syndrome.
健康受试者和代谢综合征患者中脂联素与血清脂蛋白关联的性别差异
Biomedicines. 2024 Sep 1;12(9):1972. doi: 10.3390/biomedicines12091972.
4
Serum Levels of Adiponectin Are Strongly Associated with Lipoprotein Subclasses in Healthy Volunteers but Not in Patients with Metabolic Syndrome.健康志愿者的脂联素血清水平与脂蛋白亚类密切相关,但代谢综合征患者则不然。
Int J Mol Sci. 2024 May 6;25(9):5050. doi: 10.3390/ijms25095050.
5
Reevaluating Adiponectin's impact on obesity hypertension: a Chinese case-control study.重新评估脂联素对肥胖相关性高血压的影响:一项中国病例对照研究。
BMC Cardiovasc Disord. 2024 Apr 13;24(1):208. doi: 10.1186/s12872-024-03865-4.
6
Evaluation of Adiponectin and ANGPTL8 in Women With Metabolic Syndrome in the Madinah Region of Saudi Arabia.沙特阿拉伯麦地那地区代谢综合征女性中脂联素和血管生成素样蛋白8的评估
Cureus. 2023 Aug 27;15(8):e44219. doi: 10.7759/cureus.44219. eCollection 2023 Aug.
7
Unraveling the role of resistin, retinol-binding protein 4 and adiponectin produced by epicardial adipose tissue in cardiac structure and function: evidence of a paracrine effect.解析心外膜脂肪组织产生的抵抗素、视黄醇结合蛋白 4 和脂联素在心脏结构和功能中的作用:旁分泌效应的证据。
Hormones (Athens). 2023 Jun;22(2):321-330. doi: 10.1007/s42000-023-00447-5. Epub 2023 Mar 24.
8
Links Between Adiponectin and Dementia: From Risk Factors to Pathophysiology.脂联素与痴呆之间的联系:从风险因素到病理生理学
Front Aging Neurosci. 2020 Jan 8;11:356. doi: 10.3389/fnagi.2019.00356. eCollection 2019.
9
Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives.脂联素对糖脂代谢及动脉粥样硬化进展的有益作用:机制与展望。
Int J Mol Sci. 2019 Mar 8;20(5):1190. doi: 10.3390/ijms20051190.
10
High Molecular Weight Adiponectin Levels are Neither Influenced by Adiponectin Polymorphisms Nor Associated with Insulin Resistance in Mixed-ancestry Hyperglycemic Subjects from South Africa.在南非具有混合血统的高血糖受试者中,高分子量脂联素水平既不受脂联素多态性的影响,也与胰岛素抵抗无关。
J Med Biochem. 2016 Nov 2;35(4):416-427. doi: 10.1515/jomb-2016-0024. eCollection 2016 Oct.